In our extensive experience with MAPD, national, and regional health plan clients, we understand that Star Ratings success depends heavily on triple-weighted quality measures related to medication adherence. Data shows us that most plans can’t achieve this kind of success without better resources and intervention capabilities – but plans don’t have to do it alone. RxAnte has officially patented our RxEffect Workflow and Predictive Technology. The platform helps plans see real ROI because it’s founded on the key pillars of creating and managing effective Part D adherence programs: targeting, timing, effectiveness, and scale. It both analyzes and predicts, while relieving administrative burden to allow health plan teams to reapply valuable resources where they’re most needed.

We’re so excited to help our clients get the competitive edge with this next-level medication adherence technology. Read all about it in the full press release below, or contact us for a consultation or demonstration today.

RxAnte, Inc., a leading provider of predictive analytics and targeted clinical programs for medication management, announced today the issuance of US Patent No. 10,108,975 for the development of its RxEffect® workflow solution, designed to improve patient medication use on behalf of health plans and care providers.

The patent describes the enabling technology behind RxEffect, including the process by which the system delivers prediction-driven, clinically actionable information to healthcare providers that enriches and informs patient engagement efforts. The patent also describes   prediction-driven financial incentive programs that enable value-based payments for improved medication use.

“Continuous innovation has been a core principle for RxAnte since our founding, and I’m thrilled that our team’s pioneering work has been recognized and protected with the issuance of this patent,” said Josh Benner, CEO and co-founder of RxAnte. “During the many years of helping our health plan and provider clients improve medication use, RxEffect has consistently been the most effective intervention we have evaluated.”

Currently deployed by three national health plans and utilized by more than 2,000 care managers and physician staff, RxEffect has helped its users engage in effective conversations about medication use across the country since its inception in 2013.

About RxAnte, Inc.

RxAnte, Inc. is dedicated to getting more from medicines. A trusted provider of advanced analytics and targeted clinical programs for health plans and servicing more than 8 million lives, The RxAnte® systems which are HITRUST and SOC 2 certified identify members at risk for drug therapy problems and support delivery of appropriate clinical interventions. Since 2011, this proven approach has enabled clients to improve CMS Star Ratings, HEDIS quality measures, and reduce total cost of care.